- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06001840
Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases
January 21, 2026 updated by: Roberta Freitas-Lemos, Virginia Polytechnic Institute and State University
This study will investigate the effects of promotion factors and mitigation strategies on legal and illegal tobacco purchases for different tobacco-user types.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the present study, we propose to examine some promotion factors and mitigation strategies and how they impact tobacco product legal and illegal purchases.
Specifically, we have developed an Illegal Experimental Tobacco Marketplace (iETM).
The iETM permits us to identify the number, type, and characteristics of tobacco users who would seek illegal tobacco products and the conditions that would induce them to seek that option.
The critical questions we seek to answer are whether changes in product standards and availability will engender illegal tobacco purchasing as a function of tobacco user type (e.g., exclusive combustible product users, and dual cigarette/NVP users).
Understanding the user types and the relevant conditions will inform greater tailoring of policy to diminish consumer interest in an illegal market.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Roanoke, Virginia, United States, 24016
- Fralin Biomedical Research Institute at VTC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Provide informed consent
- Be at least 21 years of age or older
- Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm)
- Stable tobacco use patterns for at least two months
For exclusive cigarette smokers:
- Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month).
- For dual cigarette/NVP users:
- Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)
Exclusion criteria:
- Have plans to move out of the area
- Have a serious or unstable physical or mental health condition
- Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement
- Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study
- Being pregnant or lactating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Exclusive cigarette smokers
Exclusive cigarette smokers will be recruited and will be exposed to all of the conditions described in the intervention section.
|
In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM.
In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.
Penalties: Penalties will be presented as a 60% chance of getting caught making illegal purchases.
The consequences of illegal purchases include not receiving any study products from the ETM if they were caught and randomly drew that trial.
|
|
Experimental: Experimental: Dual cigarette/ nicotine vaping product users
Dual cigarette and nicotine vaping product users will be recruited and will be exposed to all of the conditions described in the intervention section
|
In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM.
In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.
Penalties: Penalties will be presented as a 60% chance of getting caught making illegal purchases.
The consequences of illegal purchases include not receiving any study products from the ETM if they were caught and randomly drew that trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Budget Spent on Illegal Cigarettes Across Policy Conditions
Time Frame: 1 day
|
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC.
The average percentage of the budget spent on illegal cigarettes across all trials was calculated for each policy scenario.
|
1 day
|
|
Percent Budget Spent on Legal Cigarettes Across Policy Conditions
Time Frame: 1 day
|
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC.
The average percentage of the budget spent on legal cigarettes across all trials was calculated for each policy scenario.
|
1 day
|
|
Percent Budget Spent on E-cigarettes Across Policy Conditions
Time Frame: 1 day
|
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC.
The average percentage of the budget spent on e-cigarettes across all trials was calculated for each policy scenario.
|
1 day
|
|
Percent Budget Spent on Nicotine Replacement Therapy Across Policy Conditions
Time Frame: 1 day
|
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC.
The average percentage of the budget spent on nicotine replacement theray across all trials was calculated for each policy scenario.
|
1 day
|
|
Percent Budget Spent on Oral Nicotine/Tobacco Across Policy Conditions
Time Frame: 1 day
|
The study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC.
The average percentage of the budget spent on oral nicotine/tobacco across all trials was calculated for each policy scenario.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Roberta Freitas-Lemos, Ph.D., Fralin Biomedical Research Institute at Virginia Tech Carilion
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 4, 2024
Primary Completion (Actual)
February 28, 2025
Study Completion (Actual)
March 31, 2025
Study Registration Dates
First Submitted
August 14, 2023
First Submitted That Met QC Criteria
August 14, 2023
First Posted (Actual)
August 21, 2023
Study Record Updates
Last Update Posted (Actual)
February 10, 2026
Last Update Submitted That Met QC Criteria
January 21, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5P01CA200512 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study team will share de-identified data upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cigarette Smoking
-
Virginia Polytechnic Institute and State UniversityCompletedCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
-
Maastricht University Medical CenterCompletedCigarette Smoking | Cigarette Smoking Toxicity | Smoking BehaviorNetherlands
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingSmoking Cessation | Smoking, Cigarette | Electronic CigaretteFrance
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); University of Pennsylvania; Food and Drug Administration...Completed
-
Medical University of South CarolinaEnrolling by invitationSmoking ( Cigarette)United States
-
Duke UniversityGeorgetown University; University of MichiganWithdrawnSmoking | Cigarette Smoking | E-cigarette Use
-
Pok Oi HospitalNot yet recruitingSmoking ( Cigarette)Hong Kong
-
Ataturk UniversityCompleted
-
Masonic Cancer Center, University of MinnesotaNational Institute on Drug Abuse (NIDA)Active, not recruitingSmoking, CigaretteUnited States
-
RAI Services CompanyIPSOSCompletedSmoking CigaretteUnited Kingdom
Clinical Trials on Promotion factors
-
Children's Hospital of PhiladelphiaWilliam Penn FoundationCompleted
-
International Centre for Diarrhoeal Disease Research...Centers for Disease Control and Prevention; State University of New York at...Completed
-
The University of Texas Health Science Center at...Completed
-
National Yang Ming Chiao Tung UniversityCardinal Tien HospitalEnrolling by invitationLower Urinary Tract Symptoms | Diabetes Mellitus | Sleep | Self-management | Sleep Health | Health-related Quality of Life | Conservative ManagementTaiwan
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... and other collaboratorsCompletedOral Health Knowledge | Oral Health Attitudes | Oral Health Self-efficacyChile
-
University of ValenciaHospital Universitario La Fe; Hospital General ValenciaCompletedHealthy StudentsSpain
-
Chinese University of Hong KongCompleted
-
Université de SherbrookeVitalite Health NetworkRecruitingCardiovascular Diseases | FrailtyCanada
-
Unilever IsraelUnknownPersonal Experience and Personal Initiation Program | Health Prevention Activities | Impact on PatientsIsrael
-
Northwestern UniversityNational Cancer Institute (NCI); Fox Chase Cancer Center; University of Michigan and other collaboratorsCompleted